Precision Medicine in Pediatric Cardiology

被引：4
作者：
Kikano, Sandra [1 ]
Kannankeril, Prince J. [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Monroe Carell Jr Childrens Hosp Vanderbilt, Ctr Pediat Precis Med,Dept Pediat, Nashville, TN USA
来源：
PEDIATRIC ANNALS | 2022年 / 51卷 / 10期
关键词：
CONGENITAL HEART-DISEASE; TRANSPLANT-FREE SURVIVAL; INFANTS; SURGERY; GENOTYPES; CHILDREN; OUTCOMES; RISK; INDOMETHACIN; PHARMACOLOGY;
D O I：
10.3928/19382359-20220803-05
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Precision medicine is a developing strategy for individualized treatment of a wide range of diseases. Congenital heart disease is the most common of all congenital defects and carries a high degree of variability in outcomes because of unidentified causes. Advances have identified individual genetic and environmental factors that have helped understand variations in morbidity and mortality in pediatric cardiology. A focus on genomics and pharmacogenetics has also been key to risk prediction and improvement in drug safety and efficacy in the pediatric population. With the rapidly evolving understanding of these individual factors, there also come challenges in implementation of personalized medicine into our health care model. This review outlines the key features of precision medicine in pediatric cardiology and highlights the clinical effects of these findings in patients with congenital heart disease.
引用
收藏
页码：E390 / E395
页数：6
相关论文
共 47 条
  • [11] Population pharmacokinetic analysis of dexmedetomidine in children using real-world data from electronic health records and remnant specimens
    James, Nathan T.
    Breeyear, Joseph H.
    Caprioli, Richard
    Edwards, Todd
    Hachey, Brian
    Kannankeril, Prince J.
    Keaton, Jacob M.
    Marshall, Matthew D.
    Van Driest, Sara L.
    Choi, Leena
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2885 - 2898
  • [12] Precision Medicine, AI, and the Future of Personalized Health Care
    Johnson, Kevin B.
    Wei, Wei-Qi
    Weeraratne, Dilhan
    Frisse, Mark E.
    Misulis, Karl
    Rhee, Kyu
    Zhao, Juan
    Snowdon, Jane L.
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (01): : 86 - 93
  • [13] Patient Genotypes Impact Survival After Surgery for Isolated Congenital Heart Disease
    Kim, Daniel Seung
    Kim, Jerry H.
    Burt, Amber A.
    Crosslin, David R.
    Burnham, Nancy
    McDonald-McGinn, Donna M.
    Zackai, Elaine H.
    Nicolson, Susan C.
    Spray, Thomas L.
    Stanaway, Ian B.
    Nickerson, Deborah A.
    Russell, Mark W.
    Hakonarson, Hakon
    Gaynor, J. William
    Jarvik, Gail P.
    [J]. ANNALS OF THORACIC SURGERY, 2014, 98 (01) : 104 - 110
  • [14] The endothelin-1 G5665T polymorphism impacts transplant-free survival for single ventricle patients
    Kirshbom, Paul M.
    Mahle, William T.
    Joyner, Ronald W.
    Leong, Traci
    Wilson, Malania
    Kogon, Brian E.
    Kanter, Kirk R.
    Bouzyk, Mark M.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2008, 136 (01) : 117 - 122
  • [15] Use of dexmedetomidine in pediatric cardiac anesthesia
    Kiski, Daniela
    Malec, Edward
    Schmidt, Christoph
    [J]. CURRENT OPINION IN ANESTHESIOLOGY, 2019, 32 (03) : 334 - 342
  • [16] Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment
    Lewis, Tamorah R.
    Shelton, Elaine L.
    Van Driest, Sara L.
    Kannankeril, Prince J.
    Reese, Jeff
    [J]. SEMINARS IN FETAL & NEONATAL MEDICINE, 2018, 23 (04) : 232 - 238
  • [17] US Mortality Attributable to Congenital Heart Disease Across the Lifespan From 1999 Through 2017 Exposes Persistent Racial/Ethnic Disparities
    Lopez, Keila N.
    Morris, Shaine A.
    Sexson Tejtel, S. Kristen
    Espaillat, Andre
    Salemi, Jason L.
    [J]. CIRCULATION, 2020, 142 (12) : 1132 - 1147
  • [18] Clearance of morphine in postoperative infants during intravenous infusion: The influence of age and surgery
    Lynn, A
    Nespeca, MK
    Bratton, SL
    Strauss, SG
    Shen, DD
    [J]. ANESTHESIA AND ANALGESIA, 1998, 86 (05) : 958 - 963
  • [19] A Connexin40 Mutation Associated With a Malignant Variant of Progressive Familial Heart Block Type I
    Makita, Naomasa
    Seki, Akiko
    Sumitomo, Naokata
    Chkourko, Halina
    Fukuhara, Shigetomo
    Watanabe, Hiroshi
    Shimizu, Wataru
    Bezzina, Connie R.
    Hasdemir, Can
    Mugishima, Hideo
    Makiyama, Takeru
    Baruteau, Alban
    Baron, Estelle
    Horie, Minoru
    Hagiwara, Nobuhisa
    Wilde, Arthur A. M.
    Probst, Vincent
    Le Marec, Herve
    Roden, Dan M.
    Mochizuki, Naoki
    Schott, Jean-Jacques
    Delmar, Mario
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2012, 5 (01) : 163 - U274
  • [20] A vascular endothelial growth factor A genetic variant is associated with improved ventricular function and transplant-free survival after surgery for non-syndromic CHD
    Mavroudis, Constantine D.
    Kim, Daniel Seung
    Burnham, Nancy
    Morss, Alexandra H.
    Kim, Jerry H.
    Burt, Amber A.
    Crosslin, David R.
    McDonald-McGinn, Donna M.
    Zackai, Elaine H.
    Cohen, Meryl S.
    Nicolson, Susan C.
    Spray, Thomas L.
    Stanaway, Ian B.
    Nickerson, Deborah A.
    Russell, Mark W.
    Hakonarson, Hakon
    Jarvik, Gail P.
    Gaynor, J. William
    [J]. CARDIOLOGY IN THE YOUNG, 2018, 28 (01) : 39 - 45
12345